Tenet Healthcare Corporation THC
Set alert
268.78 USD -0.11 -0.04%
As of Nov 3, 9:32 AM ET
267.23 Day range 268.14
157.58 52-week range 283.05
- YTD
- +35.26%
- 1 year
- +33.46%
- Open
- 275.95
- Prev close
- 268.89
- Mkt cap
- 21.27B
- Vol
- 6.09K
- Avg vol
- 752.10K
- EPS
- 34.29
- P/E
- 7.79
- Div yield
- 0.00%
More statistics
- Low
- 267.23
- High
- 268.14
- Forward P/E
- 13.10
- Beta
- 1.20
- Short ratio
- 2.63
- Inst. own
- 103.12%
- Dividend
- 0.00
- Ex-div date
- Mar 12, 2000
- Earnings
- Feb 10, 2027
- 50-d avg
- 264.87
- 200-d avg
- 220.21
- 1y target
- 298.82
YTD chart
Events in this range
- Feb 11, 2026Earnings: 4.7; estimate 4.07; surprise 15.48%
- Apr 30, 2026Earnings: 4.82; estimate 4.17; surprise 15.59%
- Jul 22, 2026Earnings: 6.12; estimate 4.26; surprise 43.66%
- Sep 23, 2026Rating: BMO Capital · — → Market Perform
- Oct 16, 2026Rating: Guggenheim · Buy → Buy
- Oct 29, 2026Earnings: 6.64; estimate 4.68; surprise 41.88%
- Oct 30, 2026Rating: Guggenheim · Buy → Buy
Signals (57)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 27, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 27, 2026 | 1 week ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 24, 2026 | 1 month ago |
| RSI: Overbought | Aug 20, 2026 | 2 months ago |
| RSI: Overbought | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Aug 12, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| RSI: Overbought | Aug 4, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 24, 2026 | 3 months ago |
| RSI: Overbought | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 23, 2026 | 3 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
Newest 20 of 57.
Analyst view
Consensus: buy
Buy
Price target (mean) 298.82 +11.2% upside
Now 268.78
- Target (low)
- 265.00
- Target (mean)
- 298.82
- Target (high)
- 342.00
Ratings (0m) 23 19 buy · 4 hold · 0 sell
- Strong buy5
- Buy14
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- This month 23
- 1 month ago 23
- 2 months ago 22
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 5.41 | 4.47 – 6.09 | 4.70 | +15.0% | 5.69B | +3.0% | 19 |
| Next quarter | 4.64 | 3.85 – 5.38 | 4.82 | -3.8% | 5.45B | +1.6% | 12 |
| Current year | 22.17 | 21.05 – 23.01 | 16.78 | +32.1% | 22.46B | +5.4% | 20 |
| Next year | 20.52 | 17.92 – 23.21 | 22.17 | -7.4% | 22.52B | +0.3% | 20 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Nov 2, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 2, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 16, 2026 | Guggenheim | Maintained | Buy | Buy |
| Sep 23, 2026 | BMO Capital | Initiated | — | Market Perform |
| Sep 18, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Aug 3, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 28, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 28, 2026 | Baird | Maintained | Neutral | Neutral |
| Jul 28, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 27, 2026 | UBS | Maintained | Buy | Buy |
| Jul 27, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jul 27, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jul 27, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 24, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 20, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 13, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 9, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 22, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 5, 2026 | Barclays | Maintained | Overweight | Overweight |
| May 5, 2026 | Baird | Maintained | Neutral | Neutral |
| May 4, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| May 1, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 1, 2026 | Guggenheim | Maintained | Buy | Buy |
| May 1, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 1, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Mar 12, 2026 | Guggenheim | Maintained | Buy | Buy |
| Mar 12, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Feb 20, 2026 | Leerink Partners | Maintained | Outperform | Outperform |